Abstract
Gene therapy represents a new strategy to treat human disorders. It was originally conceived as a cure for severe monogenetic disorders. Since its conception, the spectrum of possible application for gene therapy has been to include the treatment of acquired diseases, such as various forms of cancer and some viral infections, most notably human immune deficiency virus (HIV) and hepatitis B virus. Since somatic gene therapy does not cause substantially new ethical problems, it has gained broad approval. This is by no means the case with germ-line gene therapy. Practically all bodies who were evaluating the related ethical aspects wanted to ban its medical application on grounds of fundamental and pragmatic considerations. In this review, practical and ethical views concerning gene therapy are summarized which were presented at the 'Junitagung 1994' of the Swiss Society for Biomedical Ethics in Basle.
| Translated title of the contribution | Gene therapy and ethics |
|---|---|
| Original language | German |
| Journal | Schweizerische Medizinische Wochenschrift |
| Volume | 125 |
| Issue number | 1-2 |
| Pages (from-to) | 34-41 |
| Number of pages | 8 |
| ISSN | 0036-7672 |
| Publication status | Published - 1995 |
